Comparison of drug concentrations in postmortem cerebrospinal fluid and blood specimens

Journal of Analytical Toxicology

Volumn 31, Issue 9, 2007, Pages 581-587

  Engelhart, David A ^a   Jenkins, Amanda J ^b  

^a Omega Laboratories Inc   (United States)

^b Lake County Crime Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BROMPHENIRAMINE; CHLORPROMAZINE; CLOZAPINE; CYCLOBENZAPRINE; DEXTROMETHORPHAN; DEXTROPROPOXYPHENE; DIAZEPAM; DILTIAZEM; DIPHENHYDRAMINE; IBUPROFEN; LIDOCAINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; PETHIDINE; PHENCYCLIDINE; PHENYTOIN; SEDATIVE AGENT; SERTRALINE; TRAMADOL; UNINDEXED DRUG;

ARTICLE; AUTOPSY; BLOOD SAMPLING; BODY FLUID; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG HALF LIFE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; PKA; PROTEIN BINDING; SURVIVAL;

EID: 37348999855     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.9.581     Document Type: Article

References (38)

1. Z.B. Redzic, J.E. Preston, J.A. Duncan, A. Chodobski, and J. Szmydynger-Chodobska. The choroid plexus-cerebrospinal fluid system: from development to aging. Curr. Top. Dev. Biol. 71: 1-52 (2005).
2. B.Venkatesh, P.Scott, and M. Ziegenfuss. Cerebrospinal fluid in critical illness. Crit. Care Resusc. 2(1): 42-54 (2000).
3. P. Formichi, C. Battisti, E. Radi, and A. Federico. Cerebrospinal fluid tau, Ass, and phosphorylated tau protein for the diagnosis of Alzheimer's disease. J. Cell Physiol. 208(1): 39-46 (2006).
4. K. Blennow. CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment. Expert. Rev. Mol. Diagn. 5(5): 661-72 (2005).
5. M.I. Botez and S.N. Young. Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias. Can. J. Neurol. Sci. 28(2): 134-40 (2001).
6. P. Lescuyer, L. Allard, C.G. Zimmermann-Ivol, J.A. Burgess, S. Hughes-Frutiger, et al. Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration. Proteomics 4(8): 2234-2241 (2004).
7. D.D. Shen, A. Artru, and K.K. Adkison. Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics. Adv. Drug Deliv. Rev. 56(12): 1825-57 (2004).
8. C.E. Johanson, J.A. Duncan, E.G. Stopa, and A. Baird. Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route. Pharm. Res. 22(7): 1011-37 (2005).
9. B. Rambeck, U.H. Jurgens, T.W. May, H.W. Pannek, F. Behne, A. Ebner, A. Gorji, H. Straub, E.J. Speckmann, B. Pohlmann-Eden, and W. Loscher. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia 47(4): 681-94 (2006).
10. A. Yilmaz, D. Fuchs, L. Hagberg, U. Nillroth, L. Stahle, J.O. Svensson, and M. Gisslen. Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. BMC Infect. Dis. 6: 63 (2006).
11. A. Antinori, C.F. Perno, M.L. Giancola, F. Forbici, G. Ippolito, R.M. Hoetelmans, and S.C. Piscitelli. Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma. Clin. Infect. Dis. 41(12): 1787-93 (2005).
12. G. Fleischhack, U. Jaehde, and U. Bode. Pharmacokinetics following traventricular administration of chemotherapy in patients with neoplastic meningitis. Clin. Pharmacokinet. 44(1): 1-31 (2005).
13. N. Morikawa, T. Mori, H. Kawashima, M. Takeyama, and S. Hori. Pharmacokinetics of anticancer drugs in cerebrospinal fluid. Ann. Pharmacother. 32(10): 1008-12 (1998).
14. T. Wolff, H. Samuelsson, and T. Hedner. Morphine and morphine metabolite concentrations in cerebrosphinal fluid and plasma in cancer pain patients after slow-release oral morphine administration. Pain 62(2): 147-54 (1995).
15. M.N. Dudley, R.E. Levitz, R. Quintiliani, J.M. Hickingbotham, and C.H. Nightingale. Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges. Antimicrob. Agents Chemother. 26(6): 811-4 (1984).
16. M. Buhrer, F.J. Frey, and B.M. Frey. Prednisolone concentrations in cerebrospinal fluid after different prednisolone prodrugs. Br. J. Clin. Pharmacol. 31(1): 111-3 (1991).
17. J.C. Eisenach, D.D. Hood, R. Tuttle, S. Shafer, T. Smith, and C. Tong. Computer-controlled epidural infusion to targeted cerebrospinal fluid concentrations in humans: Clonidine. Anesthesiology 83(1): 33-47 (1995).
18. M.F. Wagemans, E.N. Bakker, W.W. Zuurmond, E.M. Spoelder, A.C. Van Loenen, and J.J. De Lange. Intrathecal administration of high-dose morphine solutions decreases the pH of cerebrospinal fluid. Pain 61(1): 55-9 (1995).
19. J. Sanchez Morillo, A. Demartini Ferrari, N. Estan Capell, P. Vinals Bellido, C. Quiniones Torrelo, and M. Morales Suarez-Valera. Relation between glucose concentrations in cerebrospinal fluid and sensory and motor block during spinal anesthesia with hyperbaric bupivacaine. Rev. Esp. Anestesiol. Reanim. 53(1): 11-7 (2006).
20. S.V. Smith and D.T. Forman. Laboratory analysis of cerebrospinal fluid. Clin. Lab. Sci. 7(1): 32-8 (1994).
21. L. Rammer and B. Gerdin. Dilution of blood in fresh water drowning. Post-mortem determination of osmolarity and electrolytes in blood, cerebrospinal fluid and vitreous humor. Forensic Sci. 8(3): 229-34 (1976).
22. H. Mehnert. Glucose determination post mortem. Med. Klin. 70(36): 1442 (1975).
23. E.C. Eliakis, A.C. Eliakis, and A.S. Coutselinis. Post-Mortem variations of the pH of the blood and of the cerebrospinal fluid. (Experimental research) Ann. Med. Leg. Criminol. Police Sci. Toxicol. 46(3): 163-4 (1966).
24. F. Fraschini, E. Muller, and A. Zanoboni. Post-mortem increase of potassium in human cerebrospinal fluid. Nature 198: 1208 (1963).
25. M. Coude and P. Kamoun. Organic acids in post-mortem cerebrospinal fluid. Clin. Chim. Acta. 206(3): 201-6 (1992).
26. D. Wyler, W. Marty, and W. Bar. Correlation between the postmortem cell content of cerebrospinal fluid and time of death. Int. J. Legal Med. 106(4): 194-9 (1994).
27. B.A. Goldberger, E.J. Cone, T.M. Grant, Y.H. Caplan, B.S. Levine, and J.E. Smialek. Disposition of heroin and its metabolites in heroin-related deaths. J. Anal. Toxicol. 18: 22-28 (1994).
28. A.J. Jenkins and E.S. Lavins. 6-Acetylmorphine determination in postmortem cerebrospinal fluid. [Letter]. J. Anal. Toxicol. 22: 173-175 (1998).
29. M.J. Bogusz, R.D. Maier, and S. Driessen. Morphine, morphine-3- glucuronide, morphine-6-glucuronide, 6-monoacetylmorphine determined by means of atmospheric pressure chemical ionization-mass spectrometry-liquid chromatography in body fluids of heroin victims. J. Anal. Toxicol. 21: 346-355 (1997).
30. B.K. Logan and R. Luthi. The significance of morphine concentrations in the cerebrospinal fluid in morphine caused deaths. J. Forensic Sci. 39: 699-706 (1994).
31. A.J. Jenkins, E.S. Lavins, S. Miron, and R. Challener. Unusual distribution of morphine in biological matrices after drug delivery with an infusion system. Proceedings of the American Academy of Forensic Sciences 51st Annual Meeting, February 15-20, 1999, Orlando, FL. [Abstract K24].
32. K. Libiseller, M. Pavlic, P. Grubwieser, and W. Rabl. An announced suicide with ecstasy. Int. J. Legal Med. 21: 1-4 (2005).
33. E.L. Horak and A.J. Jenkins. Postmortem tissue distribution of olanzapine and citalopram in a drug intoxication. J. Forensic Sci. 50(3): 679-681 (2005).
34. F. Pragst, S. Herre, S. Scheffler, A. Hager, and U. Leuschner. Comparative investigation of drug concentrations in cerebrospinal fluid, vitreous humor and blood. In Proceedings of the TIAFT/SOFT Joint Congress on Forensic Toxicology, 1994, Tampa, FL, V. Spiehler, Ed. Newport Beach, CA, 1995, pp 281-291.
35. F. Moriya and Y. Hashimoto. A fatal poisoning caused by methomyl and nicotine. Forensic Sci. Int. 149(2-3): 167-70 (2005).
36. F.M. Leweke, A. Giuffrida, U. Wurster, H.M. Emrich, and D. Piomelli. Elevated endogenous cannabinoids in schizophrenia. Neuroreport. 10(8): 1665-9 (1999).
37. F. Moriya and Y. Hashimoto. Pericardial fluid as an alternative specimen to blood for postmortem toxicological analyses. Leg. Med. (Tokyo) 1(2): 86-94 (1999).
38. G. Kernbach, S. Picht, B. Brinkmann, and K. Puschel. Initial results of postmortem diagnosis of diabetes mellitus by Hb A1 determination. Z. Rechtsmed. 90(4): 303-8 (1983).